The CSF1R/IL12‐MM‐liposome hybrid nanovesicles would inherit properties from source materials including BBB crossing, GBM targeting, immunomodulatory effects, and long‐term circulation and colloidal stability. This evidence concerns the gene CSF1R and glioblastoma.